 - Preliminary Dose Escalation Data to be Presented on Novel CDK29 Inhibitor Fadraciclib in Patients with Solid Tumors and Lymphoma - - Preliminary Dose Escalation Data to be Presented on Novel CDK29 Inhibitor Fadraciclib in Patients with Solid Tumors and Lymphoma - 